The Latest Breaking News from Medtronic

These 3 Dividend Aristocrats Look Ready to Rebound in 2026. Should You Buy Them Now?

Three oversold Dividend Aristocrats near recent lows offering reliable income, strong analyst support, and significant upside potential.

Barchart · Feb 21

Medtronic’s “Textbook” Reversal: How High Can It Really Go in 2026?

Medtronic's stock price reversal gained traction in late fiscal 2025, setting the market up for a 2026 rally, potentially hitting $125.

MarketBeat · Feb 17

Option Volatility And Earnings Report For February 16 - 20

Earnings season is starting to slow down now, which may come as a welcome relief for some. However, we do still have some important companies due to report with Walmart, Alibaba, Newmont Mining, Medtronic, Palo Alto Networks, DoorDash and Occidental Petroleum all set to report.

Barchart · Feb 16

This Medical Device Maker Is Seeing High Demand In Cardiovascular, Diabetes Business

Medtronic Plc (NYSE:MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase year-over-year, with organic growth of 5.5%.

Benzinga · Nov 18, 2025

Option Volatility and Earnings Report for November 17 - 21

It’s a big week for earnings this week with Nvidia and some key retail names taking center stage. This week we have Nvidia, Home Depot, Walmart, Target, Lowes, Palo Alto Networks, Medtronic and Pdd Holdings all reporting.

Barchart · Nov 17, 2025

Is Wall Street Bullish or Bearish on Medtronic Stock?

Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

Barchart · Nov 4, 2025

What to Expect From Medtronic's Q2 2026 Earnings Report

Medtronic is expected to release its second-quarter results next month, and analysts project a single-digit earnings increase.

Barchart · Oct 27, 2025

Medtronic Kicks Off US Study On Robot-Assisted Surgeries For Women

Medtronic plc (NYSE:MDT) Wednesday announced the commencement of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to assess the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system in gynecological procedures.

Benzinga · Oct 8, 2025

Medtronic's New Implant Could Transform Bladder Control Treatment

Innovative medical technologies are transforming healthcare by tackling chronic conditions that affect millions, offering hope and improved quality of life. The Food and Drug Administration (FDA) approved Medtronic plc’s (NYSE:MDT) Altaviva device on Friday.

Benzinga · Sep 19, 2025

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga · Sep 17, 2025